https://www.selleckchem.com/pr....oducts/ozanimod-rpc1
97-199.93) had higher odds for unsuccessful TB treatment outcome. Nearly half of the patients with TB-HIV had unsuccessful TB treatment outcome. Therefore, it is important to ensure that such patients receive DOTS and continuous TB treatment of 6 months. It is crucial to strengthen and widen the coverage of DOTS, especially among high-risk groups, in healthcare settings. Strict follow-up by healthcare providers is needed for patients with TB-HIV to gain treatment adherence and for better rates of successful TB treatment. 6
Gefällt mir
Kommentar
Teilen
